Reporter Jan 25 2019 Archive
-
January 24, 2019
American Chemical Society honors Lindsley’s research
The year is starting off with a bang for Craig Lindsley, PhD, director of medicinal chemistry in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD). -
January 24, 2019
Department of Medicine debuts new shared space in Oxford House
The fifth floor of the Oxford House has been remodeled into an innovative shared space for several groups in the Department of Medicine to use on an as-needed basis. -
January 24, 2019
Children’s Hospital lands awards for health communications
Monroe Carell Jr. Children’s Hospital at Vanderbilt took home top honors in multiple categories in the 2018 eHealthcare Leadership Awards, which recognizes the nation’s best in health care digital communications. -
January 24, 2019
VUMC scientists ‘sprint’ to find anti-Zika antibodies
Scientists at Vanderbilt University Medical Center and colleagues in Boston, Seattle and St. Louis are racing to develop — in a mere 90 days — a protective antibody-based treatment that can stop the spread of the Zika virus. -
January 24, 2019
Radiologist Taber thrives on teaching, diagnostic challenges
David Taber, MD, has practiced radiology for more than 40 years, with the first half of his career spent in private practice and the second half at Vanderbilt University Medical Center. In addition to his clinical practice within the musculoskeletal and emergency radiology section of the Department of Radiology, Taber serves as an assistant director of the diagnostic radiology residency program. -
January 24, 2019
Pierce’s presence brightens days in Trauma ICU
As he walks the hallways of the Trauma Intensive Care Unit at Vanderbilt University Medical Center, Don Pierce’s gold Guest Services blazer is an outward symbol of the heart of gold you’ll find underneath. -
January 23, 2019
Major grant to bolster research on inflammation-related cancers
Cancer Research UK has awarded a 20-million-pound grant (about $25 million U.S.) to a team of international investigators, including Vanderbilt’s James Goldenring, MD, PhD, to study inflammation-related cancers.